Author Profile

About
Latest Posts

Michael A. Nauck, Bochum, Germany. Professor Michael Nauck is Head of Clinical Research, Diabetes, at the St. Josef Hospital, Ruhr-University Bochum, and has studied the physiology and pathophysiology as well as the therapeutic potential of the incretin hormones GIP and GLP-1 for 40 years. He was involved in proof-of-principle studies outlining the therapeutic potential of GLP-1 for type 2 diabetes.

Latest posts by Michael A. Nauck and David A. D‘Alessio (see all)

The most effective medication for weight loss and blood glucose stabilization: Tirzepatide - 11th January 2023

The most effective medication for weight loss and blood glucose stabilization: Tirzepatide

11/01/2023

On Medicine

Tirzepatide is a new medication offering near-healthy control of blood glucose concentrations and substantial weight loss for patients with type 2 diabetes or… Read more »

Author Profile

The most effective medication for weight loss and blood glucose stabilization: Tirzepatide

Our blogs

Latest BioMed Central Articles